Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease

    • Autoimmune Disorder
    • Crohn's Disease
    • Inflammatory Bowel Disease (IBD)
    • Ulcerative Colitis